ACCESS TO MONOCLONAL ANTIBODIES IN AFRICA: A CALL TO ACTION

IAVI and Impact Global Health report evaluating the current state of research and development (R&D) and access for monoclonal antibodies (mAbs) and related products. The report, funded by Wellcome, is a four-year retrospective on the availability of mAbs and biosimilars globally — with new insights into the African region that could serve as a bellwether for progress globally.